Bupropion may be most beneficial for patients who have both depression and overweight or obesity, as it could offer dual benefits
Kidney markers Creatinine and estimated glomerular filtration rate (eGFR) require careful interpretation during tirzepatide treatment
These are not cosmetic questions
Acknowledgements Medical writing and editorial support were provided by Nicole Cash, PhD, and Abbey Pearson, MSci, of Axis, a division of Spirit Medical Communications Group Limited (and were funded by Novo Nordisk Inc.) in accordance with Good Publication Practice 3 (GPP3) guidelines ( Ethics declarations Funding This trial and medical writing support for the publication were funded by Novo Nordisk A/S, Sborg, Denmark
Others need more support, especially if they have struggled for years or if their risk profile is becoming more serious
During treatment, periodic lab checkstypically every 3 to 6 monthsallow early detection of any decline in kidney function or electrolyte shifts